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ABSTRACT
Thymidine depletion is toxic to virtually all actively
growing cells. The fundamental mechanism respons-
ible for thymidineless death remains unknown. One
event thought to be critical in causing the toxicity of
thymidinedepletionisasharpriseintheratioofdUTP
to dTTP and subsequent incorporation of dUTP into
DNA. Maneuvers to alter dUTP levels appear to alter
the toxicity of thymidine depletion. However, loss of
uracil-DNA-N-glycosylase activity does not appear to
change the toxicity of thymidine deprivation signific-
antly. This study proposes to define the role of uracil
base excision repair (BER) in mediating thymidine-
less death. The toxicity of thymidine deprivation
induced by the antifolate aminopterin was measured
in a series of mutant Saccharomyces cerevisiae
strains deficient in various steps in uracil-BER.
Most mutants displayed modest changes in their
sensitivity to aminopterin, with the exception of
cells lacking the abasic endonuclease Apn1. apn1
mutants displayed a profound sensitivity to aminop-
terinthatwasrelievedinanapn1ung1doublemutant.
Wild-type and apn1 mutants displayed similar levels
of DNA damage and S-phase arrest during aminop-
terin treatment. A significant portion of cell killing
occurred after removal of aminopterin in both wild-
type and apn1 mutant cells. apn1 mutants showed
a complete inability to re-initiate DNA replication
following removal of aminopterin. These findings
suggestrecoveryfromarrestisacrucialstepindeter-
miningtheresponsetothymidinedeprivationandthat
interruptions in uracil-BER increase the toxicity of
thymidinedeprivationbyblockingre-initiationofrep-
lication rather than inciting global DNA damage.
Inhibition of apurinic/apyrimidinic endonuclease
may therefore be a reasonable approach to increase
the efficacy of anticancer chemotherapies based on
thymidine depletion.
INTRODUCTION
Depletion of thymidine is toxic to virtually all actively grow-
ing cells. Originally described by Barner and Cohen in 1954
(1), thymineless death has been reported in bacteria, yeast and
mammalian cells (2).De novosynthesisofdTMP iscarried out
by the enzyme thymidylate synthase which converts dUMP to
dTMP in a one carbon transfer to the 50 position of dUMP. The
one carbon group is donated by tetrahydrofolate which is
regenerated bythe enzyme dihydrofolate reductase. Decreased
dTMP production can therefore be accomplished by either
inhibiting thymidylate synthase or by inhibiting dihydrofolate
reductase. The toxicity of thymidine depletion is the basis for
chemotherapeutic agents including methotrexate (a dihydro-
folate reductase inhibitor), ﬂuorouracil and 50-ﬂuoro,20-deoxy-
uridine which are converted to a metabolite (FdUMP) capable
of inhibiting thymidylate synthase.
The exact mechanism underlying thymidineless death
remains elusive. Inhibition of thymidylate synthase not only
decreases dTMP pools but also increases dUMP pools. Ingra-
ham et al. (3) showed a 10000 fold change in the ratio of
dUMP to dTMP in cultured human lymphoblasts treated with
methotrexate. Similar changes have been described by
Tinkelenberg et al. (4) in a strain of Saccharomyces cerevisiae
with a low activity allele of dUTPase. The rise in dUMP levels
may result in a rise in dUTP levels, since dUMP is derived
from dUTP. Most DNA polymerases have poor discrimination
between dTTP and dUTP (5); therefore, a dramatic rise in the
dUTP to dTTP ratio may result in signiﬁcant incorporation of
dUTP into DNA. Attempted repair of deoxyuridine residues
from DNA without adequate dTTP available to complete the
repair reaction has been suggested to create multiple single
strand breaks, and eventually double strand breaks, in a so-
called ‘futile cycle’ of repair (6). Indeed, single and double
strandbreaksdoaccumulate inthymidinedeprived cells (7).In
this model, loss of uracil glycosylase activity should decrease
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decrease the toxicity of thymidine depletion. However, loss
of uracil glycosylase activity in some systems has no impact
on the sensitivity of cells to thymidine deprivation (8).
Deﬁning the role of uracil repair in mediating the toxicity of
thymidine deprivation is challenged by the toxicity of excess
amounts of uracil in DNA. dUTPase (dut) mutants of both
yeast and Escherichia coli are inviable (9,10), potentially
owing to high rates of dUTP incorporation into DNA.
Thus, dut mutations and thymidine starvation both result in
increased uracil laden DNA. Using a deletion mutation for dut,
el-Hajj et al. (11) showed complete loss of dUTPase activity in
a uracil glycosylase deﬁcient strain of E.coli can lead to
replacement of >90% of thymidine with uracil residues in
DNA. The strain was not viable, implying that uracil laden
DNA itself is toxic. In yeast, DUT1 is also an essential gene.
Gadsden et al. (10) used a conditional allele of dUTPase to
show loss of dUTPase activity leads to death. When dUTPase
was inactivated in a uracil glycosylase deﬁcient background,
cells deﬁcient in both dUTPase and uracil glycosylase actually
lost viability more rapidly than isogenic cells lacking only
dUTPase. These data suggest the presence of uracil in DNA
may be more toxic than the attempted repair.
The repair of deoxyuridine from DNA has been extensively
studied both in vitro and in vivo and serves as a model for base
excision repair (BER) (12,13). Key features of the repair path-
way in S.cerevisiae are shown in Figure 1. To clarify the role
of DNA repair in mediating the toxicity of thymidine depriva-
tion, the response to aminopterin, an antifolate, was determ-
ined in a series of mutants deﬁcient in uracil BER.
MATERIALS AND METHODS
Strains
S.cerevisiae strains from two backgrounds were used in these
studies.Parentalandmutantstrainsinthe BY4741 background
were obtained from Open Biosystems (Huntsville, AL).
Mutants in this strain have been described elsewhere (14)
and contain deletions extending from the start codon through
thestop codonforthegene ofinterest.Thedeletedendogenous
gene is replaced with a neomycin resistance gene.
Additional studies were carried out in strains derived from
SSL204 his3 ade2 leu2 ura3 trp1 (15) as indicated. Mutations
in various repair genes were introduced into this strain using
lithium transformation of linear DNA (16). Deletion alleles
replaced by the neomycin resistance gene from the BY4741
background were transferred into the SSL204 background by
transforming linear DNA obtained by PCR using primers 1 kb
upstream and 1 kb downstream of the transferred locus. When
required, the locations of the PCR primers were adjusted to
amplify sequences outside genes adjacent to the transferred
locus. Deletion alleles marked with HIS3 or TRP1 were cre-
ated by using the method described by Burke et al. (16,17).
Linear DNA for transformation was created by PCR utilizing
60 base primers containing 40 bases complementary to the
immediate 50 or 30 coding sequence of the gene to be deleted.
The 30 20 bases of the primers were complementary to
sequences ﬂanking either the HIS3 or TRP1 gene in plasmids
pRS313 or pRS424 (18).
Aminopterin treatment
Cultures were grown overnight in minimal medium supple-
mented with 0.2% norite treated casamino acids and 20 mg/ml
of tryptophan, adenine and uracil, pH 6.0. Cultures were
diluted 1:100 into fresh medium and outgrown 4 h. Cell dens-
ity was then determined, and 10
5 cells/ml were placed into
fresh medium described above but also containing 6 mg/ml
sulfanilamide and 0.2 mg/ml aminopterin (Sigma Aldrich,
Figure 1. Schematic view of uracil base excision events occurring after
incorporation of dUTP in place of dTTP into DNA. The S.cerevisiae protein
thoughttobemostactiveateachstepisnotedinparentheses.Seetextforfurther
details.
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autoclaving (19). Aliquots from the culture were removed at
indicatedtimes,dilutedinwaterandplatedtosolidYPD(yeast
extract, peptone and dextrose) medium. Cultures without drug
wereestablishedandplated inparalleltoensureviabilityofthe
cells.
Methylene blue
Cells from treated and untreated cultures were stained with
methylene blue as described by Sami et al. (20).
Flow cytometry
Cultures were grown as described above, except the drug
treatment was performed at a cell density of 10
6 cells/ml.
At various time points, 10
7 cells were removed, washed in
water and resuspended in 70% ethanol. Cells were prepared
similarly to the procedure described by Paulovich and
Hartwell (21). Brieﬂy, cells were collected, resuspended in
water, collected again, and resuspended in 70% ethanol.
Cells were then incubated at 4 C on a rotating table for
3–24 h before being collected and resuspended in 50 mM
sodium citrate buffer (pH 7.5) and treated with RNase A
and proteinase K. The cells were incubated with propidium
iodide overnight and then sonicated. Cells were analyzed in a
Becton Dickson FACscan.
QPCR assay
Total DNA was extracted from aminopterin-treated samples
using a MasterPure  Yeast DNA Puriﬁcation Kit (Epicentre,
Madison, WI) according to the manufacturer’s instructions.
DNA concentration was determined with the Quant-iT 
PicoGreen  dsDNA Assay Kit (Molecular Probes, Eugene,
OR), adjusted to 3 ng/ml, and conﬁrmed with PicoGreen on a
SPECTRAFluor Plus microplate reader (Tecan, Research
Triangle Park, NC) at an excitation wavelength of 485 nm
and emission of 535 nm. DNA damage was analyzed by a
quantitative PCR method adapted from Santos et al. (22),
followed by PicoGreen staining. The oligo pair designed to
amplify a 9.3 kb region of chromosome XIII including genes
PFK2 and HFA1 were 50-CAA AGA ACC GTC ACC ACC
ACA AA-30 and 50-CGC TAA AAT CCC GTG TAT CCC
TTG-30. Quantitative PCR was performed with the Gen-
eAmp  XL PCR Kit (Applied Biosystems, Foster City,
CA) on an MJ Research PTC-200 DNA Engine (Bio-Rad
Laboratories, Inc., Waltham, MA). The reaction mixture con-
tained 12 ng of DNA, 1· XL Buffer II, 100 ng/ml BSA, 200
mM of dNTPs, 10 pmol of each primer and 0.8 mM of Mg
2+.
Followingahotstart,0.2UofrTthpolymerasedilutedinwater
were added. Cycling conditions were as follows: hot start at
75 Cfor2min,initialdenaturationat94 Cfor1min,followed
by 22 cycles of 15 s at 94 C and 12 min at 65 C, and a ﬁnal
10 min extension at 72 C. PCR products were initially
visualized by ethidium bromide gel electrophoresis and then
analyzed by PicoGreen quantitative analysis.
RESULTS
Changes in dUTP to TTP ratio, uracil incorporation into DNA
and subsequent repair events to excise and replace uracil
may all potentially contribute to the toxicity of thymidine
depletion. This study explores the connection between
uracil-DNA BER (shown in Figure 1) and thymidine depriva-
tion toxicity by examining the sensitivity of mutants in uracil-
DNA BER to aminopterin. Aminopterin was used to inhibit
dihydrofolate reductase and sulfanilamide to inhibit de novo
synthesis of reduced folate. Together, these agents induce
thymidine deprivation by removing the source of the one
carbon group transferred to dUMP by thymidylate synthase
toformdTMP(19). Isogenic strainsofS.cerevisiae differing at
nonessential loci involved in uracil-DNA repair were treated
with aminopterin as described in Materials and Methods. The
survival of cultures following a 24 h exposure to aminopterin
and sulfanilamide is shown in Table 1. In wild-type BY4741
cells under the conditions used here, a 24 h exposure led to
23% survival. Uracil glycosylase (ung1) mutants and rad27
mutants showed a slightly altered sensitivity to aminopterin
with survival of 36 and 2.3%, respectively. The rad27 mutants
formed adherent clusters resistant to sonication in response to
aminopterin, thereby probably giving an underestimate of
survival by the clonogenic survival assay. DNA ligase null
mutants are not viable and were therefore not examined. DNA
polymerase e has been implicated in DNA repair synthesis
following uracil excision (13). Cells without this polymerase
activity are not viable; however, some subunits of the poly-
merase can be deleted without loss of viability. Mutants lack-
ing a subunit of polymerase e are viable but have increased
mutation rates (23,24). These subunit mutants, dpb3 and dpb4,
Table 1. Survival after 24 h in Aminopterin plus Sulfanilamide medium
Relevant genotype % survival, 24 h SD t-Test
(A) BY4741 background
a
Wild-type 22.8 8.7
ung1 36.0 6.6 0.05
apn1 (6 h) 1.1 0.06 0.001
b
apn1 (24 h) 0.08 0.008 8.8 · 10
 8
apn2 39.3 18 0.25
pol32 33.3 21 0.49
rad27 2.3 0.6 2.6 · 10
 7
dpb3 13.3 0.6 9.0 · 10
 4
dpb4 9.3 4.9 0.014
(B) SSL204 background
c
Wild-type 10.8 4.4
ung1 11.2 5.4 0.9
apn1 0.03 0.01 <0.05
rad27 11.0 5.8 0.95
(C) apn1 combination mutants in SSL204 background
d
apn1 ung1 12.7 1.5 0.005
apn1 ntg1 ntg2 0.04 0.01 0.54
apn1 rev3 (12 h)
e 0.10 0.01 0.82
apn1 apn2 0.09 0.04 0.33
aVarious mutants in the uracil-BER pathway in the BY4741 background were
treatedwithaminopterinandsulfanilamideasdescribedinMaterialsandMeth-
ods.Followinga24hexposure,portionsoftheculturewerecollectedandplated
torichYPDmedium.Colonieswerecountedafter4days.Survivalisreportedas
the number of colony forming units per milliliter at 24 h/colony forming units
per milliliter at time zero. apn1 mutants were assessed at earlier time points
given the lack of sufficient survivors at 24 h.
bCompared with wild-type at 6 h.
cAminopterin sensitivity was determined as described above for mutants gen-
erated in the SSL204.
dAminopterinsensitivityofapn1mutantstrainsbearingmutationsinadditional
DNA repair genes.
eCompared with apn1 at 12 h.
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to wild-type cells.
In contrast to the modest changes in sensitivity seen for
the above mutants, we found a profound sensitivity to aminop-
terin in apn1 mutants. At 6 h of aminopterin treatment, wild-
type and other mutants examined showed a plateau in the
concentration of viable cells in the culture. In contrast,
apn1 mutant cultures demonstrated a survival of 1%. Thymi-
dine deprivation for 24 h led to a >250-fold difference in
survival between wild-type and apn1 mutants. This is the
largest difference in survival reported for any single mutation
in S.cerevisae for thymidine deprivation to the best of our
knowledge.
In order to conﬁrm these ﬁndings in an independent strain of
S.cerevisiae and address the possibility of strain background
contributing to these ﬁndings, the apn1, ung1 and rad27 genes
in parental strain SSL204 (15) were disrupted [Figure 2 and
Table 1, (B)]. Using the SSL204 derivatives, extreme sensitiv-
ity in the apn1 mutant was again observed, highlighting the
potential importance of Apn1 in mediating the response to
thymidine deprivation. The SSL204:rad27 mutant did not
aggregate upon exposure to aminopterin and had a survival
rate comparable with the SSL204 parental strain by the clono-
genic survival assay. These ﬁndings suggest that the role of
Rad27 in mediating the toxicity of thymidine deprivation may
be limited. The extreme sensitivity of apn1 deletion seen in
both strains suggests that blocking the BER pathway specif-
ically at the abasic incision step is extremely toxic to thymi-
dine deprived cells.
The UNG1 gene in an apn1 mutant was disrupted to further
characterize the sensitivity of apn1 mutants. Deletion of uracil
glycosylase should prevent the formation of abasic sites and
prevent the extreme toxicity seen in apn1 mutants. The double
apn1 ung1 mutant showed aminopterin sensitivity comparable
with wild-type cells, demonstrating signiﬁcant protection of
apn1 mutant cells by the additional loss of uracil glycosylase
activity[Figure2andTable 1,(C)].Theprotectionafforded by
deletion of the uracil glycosylase gene conﬁrms that attempted
Figure 2. (A) Survival of wild-type, apn1 ung1 and apn1 strains in the SSL204 background. Cultures of the indicated genotype were treated with aminopterin and
sulfanilamide.AtvarioustimesportionsofthecultureswereremovedandplatedtorichYPDmedium.Colonieswerecountedafter4days.Survivalisdeterminedas
thenumberofcolonyformingunitsatagiventimerelativetotheinitialconcentrationofcolonyformingunitspermilliliter.Thesensitivityofapn1mutantsisrelieved
inapn1ung1doublemutants.(B)Thesensitivityofapn1mutantsisnotrelievedinapn1ntg1ntg2triplemutants.Wild-type,apn1andapn1ntg1ntg2mutantswere
treated with aminopterin and sulfanilamide as described in Materials and Methods. Survival was determined by plating portions of the culture to rich medium at
various times of drug exposure. (C) The sensitivity of apn1 mutants is not relieved in apn1 rev3 double mutants. Survival was determined as described previously.
SSL204parentalstrainisclosedsquare,apn1isgraycircle,apn1ung1mutantstrainisopentriangle,apn1ntg1ntg2isopendiamondandapn1rev3isopensquares.
Nucleic Acids Research, 2005, Vol. 33, No. 20 6647repairofuracilisresponsibleforthe severe toxicityofaminop-
terin in apn1 mutants.
One potential explanation for the aminopterin sensitivity
seen in apn1 mutants is that abasic sites formed during
uracil-BER become substrates for less efﬁcient or outright
toxic alternate repair pathways. Attempting DNA repair dur-
ing thymidine depletion may result in entry into a repair path-
way that cannot be completed. Since BER of uracil involves
strand cleavage, stalled or incomplete repair events may be
more toxic than the initial repair substrate, uracil-DNA. Aba-
sic sites can be repaired by alternative pathways (13), particu-
larly in the absence of Apn1. Two alternative pathways
involved in abasic DNA metabolism were examined. Ntg1
and Ntg2 are S.cerevisiae homologs of E.coli endonuclease
III and, like endonuclease III, are BER enzymes with broad
speciﬁcity. Ntg1 and Ntg2 have an associated AP lyase activ-
ity which, unlike AP endonuclease, cleaves 30 to the AP site in
a beta elimination reaction, leaving a 30 a–b unsaturated alde-
hydic (30dRP) end. Strand cleavage by this mechanism thus
can create toxic 30 blocked ends unsuitable for priming DNA
repair synthesis. Hanna et al. (25) showed that S.cerevisiae
mutants lacking AP endonuclease activity are very sensitive to
DNA methylation damage normally repaired by BER. They
further showed that this sensitivity can be relieved by deletion
of NTG1 and NTG2 and concluded that in the absence of
functional AP endonuclease activity, abasic sites are acted
upon by the lyase activity of Ntg1 and Ntg2 to create toxic
repair intermediates. Therefore, inactivating NTG1 and NTG2
avoided these intermediates and allowed forincreased survival
during methylation damage (25). To determine if similar
pathways were operating during thymidine starvation, a triple
mutant strain with deletions in APN1, NTG1 and NTG2 was
created and found to remain very sensitive to aminopterin
(Figure 2). The sensitivity of the triple mutant suggests that
the extreme sensitivity of apn1 mutants is not due to shuttling
abasic repair intermediates into a pathway which creates more
toxic intermediates via Ntg1 or Ntg2 abasic lyase activity.
Abasic sites can also be bypassed by translesional synthesis
which may be mutagenic and could result in accumulation of a
large number of potentially toxic mutations. To determine if
the sensitivity of apn1 mutants was due to translesional syn-
thesis,the aminopterinsensitivity ofapn1 rev3 double mutants
was examined. Rev3 is a component of polymerase z, known
to be active in error prone translesional synthesis. The double
mutants were essentially as sensitive to aminopterin as apn1
single mutants (Figure 2). This suggests that the extreme sens-
itivity of apn1 mutants is not due to shuttling of abasic site
lesions into a translesional bypass pathway. Taken together,
these observations suggest that unrepaired abasic sites or the
block imposed by apn1 deletion are extremely toxic in thy-
midine starved cells.
S.cerevisiae contains an additional AP endonuclease, Apn2,
identiﬁed by its homology to other AP endonucleases (26).
apn2deletion mutantshave asensitivitytoaminopterinsimilar
to wild-type cells [Table 1, (A)]. The sensitivity of apn1 and
apn1 apn2 mutants in the SSL204 background was determ-
ined. After 24 h of aminopterin, the apn1 mutant showed
0.03% (SD 0.000 2) survival and the apn1 apn2 double mutant
showed 0.09% survival (SD 0.04, not signiﬁcantly different
P > 0.05). The parental SSL204 survival is 10.8%. The double
apn1 apn2 mutant has a sensitivity similar to the apn1 mutant,
suggesting that Apn2 activity is not responsible for creating
toxicity during aminopterin treatment in apn1 mutant cells.
The genetic analyses shown above failed to provide evid-
ence that alternative abasic repair contributes to the toxicity
seen in apn1 mutants. To assess the possibility that DNA
damage not mediated by Apn2, Ntg1, Ntg2 or Rev3 was
responsible for the sensitivity of apn1 mutants, DNA from
aminopterin treated cells was examined. Since several types
of DNA damage may be initiated by thymidine deprivation,
including single and double strand breaks, stalled replication
and recombination intermediates and potentially DNA–
protein cross links (27–29), DNA damage was assessed
with a non-discriminatory, broad speciﬁcity PCR assay
described by van Houten et al. (30) and shown to be effective
in determining the extent of DNA damage from divergent
sources including cisplatin, oxidative injury and UV light.
In this assay, DNA puriﬁed from cells prior to and following
aminopterin treatment is quantiﬁed and used as template to
produce a 9.3 kb fragment from chromosome XIII (22). Con-
ditions for the reaction are standardized such that the amount
of PCR product DNA is proportional to the amount of intact
template DNA present in the reaction. Double strand and
single strand breaks decrease the efﬁciency of the reaction.
Other DNA lesions, such as abasic sites, also interfere with the
progress of DNA polymerase along the template and will
decrease the amount of product. During aminopterin exposure,
the amount of viable template decreases with time equally in
wild-type and apn1 mutant cells (Figure 3). The nature of the
obstructing lesion in aminopterin treated cells cannot be
determined by this assay; however, the PCR ﬁndings suggest
that the signiﬁcant sensitivity of apn1 mutants is not due to
preferential DNA degradation or damage in apn1 mutants.
Figure 3. Wild-type and apn1 mutants were exposed to aminopterin and sul-
fanilamide as described previously.Portionsof theculturewere collectedprior
to drug exposure, at 6 h and at 12 h, and DNA was purified as described in
Materials and Methods. PCR was performed using the conditions and primers
characterized by van Houten (30). PCR product was quantified using the Pico-
Greenassay.TheamountofproductPCRatagiventime-pointwasnormalized
to the amount of product derived from input DNA from the pre-drug treatment
DNA. Parental SSL204 is closed squares and SSL204 apn1 mutants are gray
circles.
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to aminopterin among uracil-BER mutants. DNA damage and/
or repair probably plays a role in the sensitivity of apn1
mutants since their sensitivity is absent in the ung1 apn1
double mutant. Since apn1 mutants are much more sensitive
to aminopterin than wild-type cells, yet show comparable
DNA damage during exposure, the effects of aminopterin
exposure on viability of wild-type and apn1 mutants after
removal of the drug and during recovery were examined.
The colony formation assays used above cannot determine
precisely when the toxicity of thymidine deprivation occurs;
therefore, methylene blue viability staining was used to char-
acterize the timing of aminopterin toxicity more closely. Cul-
tures of both wild-type and apn1 mutants were treated with
aminopterin as in previous experiments with the exception of
increasing the cell concentration to 10
6 cells/ml. The higher
cell density allowed collection of adequate numbers of cells
for additional ﬂow cytometry studies described below. At
various times, portions of the cultures were removed and
stained with methylene blue. Although both living and dead
cells take up methylene blue, only living cells are able to
convert the dye to a colorless compound, leaving dead cells
blue (20). At the same time points, portions of the cultures
were also plated to rich medium to determine viability via
clonogenic survival as in prior experiments. At 12 h, cells
from a portion of the drug treated culture were collected,
washed and resuspended in an equal volume of fresh medium
without aminopterin and sulfanilamide. The results are shown
in Figure 4. The effects of aminopterin on colony formation
during exposure were similar to the effects described above
(Figure 4A and B). In contrast to the viability determined by
plating, viability determined by methylene blue staining
remained high for both strains until after 18 h after of drug
exposure. At times later than 18 h, cultures for both wild-type
and apn1 mutants began to show loss of viability by methylene
blue staining. This observation suggests the toxicity of thymi-
dine starvation may not be as immediate as the colony forma-
tion data suggest.In other words, 12hof aminopterinexposure
leads to decreased colony formation ability but does not result
in immediate cytotoxicity. The cultures that had been switched
to drug-free medium showed a continued loss of viability by
methylene blue staining even after removal from aminopterin.
AB
Figure 4. Wild-type and apn1 mutants were exposed to aminopterin and sulfanilamide as described previously, except in this experiment the cell concentration of
exposed cultures was increased to 10
6 cells/ml. In addition, at 12 h, a portion of the culture was collected, washed and resuspended in fresh medium without drug.
Aportionofthe culturewasalso maintainedin drug-containing medium.Survivalwasdeterminedasdescribedpreviouslyandis shownin (Aand B).To determine
theviabilityofcellsimmediatelyaftertreatment,aportionoftheculturewasstainedwithmethyleneblueand100cellswerecounted.Cellswithbluecytoplasmwere
scoredasdead,whilethosewithclearcytoplasmwerescoredasalive.Stationaryphasecellswereusedascontrolsforlivingcellsandethanoltreatedcellswereusedas
controlsfordeadcells.Methylenebluestainingshowsaslightdecreaseinviabilityforapn1mutantsfollowing24hinaminopterinandsulfanilamidebutalsosuggests
much of the toxicity of drug treatment occurs after drug exposure. Closed symbols represent continuously treated cultures; open symbols represent cultures treated
with drug before being switched to drug-free medium at 12 h. Wild-type cells are squares; circles are apn1 mutants.
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type and apn1 mutants, 6 h after removal of aminopterin. The
differences between clonogenic survival and methylene blue
viabilityandtheobservationthattoxicitybystainingcontinues
despite a switch to drug-free medium suggest that at least a
portion of toxicity resulting from aminopterin treatment
occurs after and not during drug exposure.
To further characterize changes in DNA during and after
aminopterin exposure, treated and recovering cells were
examined by ﬂow cytometry. Thymidine depletion, similar
to hydroxyurea induced dNTP depletion, is known to create
an S-phase arrest (31). Mutants unable to execute a fully
functional arrest are sensitive to dNTP depletion resulting
from hydroxyurea exposure (32). If indeed a signiﬁcant por-
tion of the toxicity of thymidine deprivation occurs after and
not during drug exposure, cell cycle arrest and recovery kin-
etics in wild-type and apn1 mutants may be informative. A
portion of the cultures examined in the above methylene blue
experiment (Figure 4) were collected and analyzed by ﬂow
cytometry to determine DNA content changes in response to
aminopterin treatment and drug-free regrowth. The results are
shown in Figure 5. The response to aminopterin in ung1
mutants and apn1 ung1 double mutants by ﬂow cytometry
was also determined. The results in Figure 5 show wild-
type, apn1, ung1 and apn1 ung1 double mutant cells all arres-
ted inSphase during aminopterintreatment, consistentwithits
activity as a DNA replication blocking agent. Upon removal of
drug, wild-type cells were able to re-initiate DNA synthesis
and re-enter the cell cycle. apn1 mutants, though viable by
methylene blue assay, were not able to re-enter the cell cycle
and remained ﬁxed in S phase. This observation suggests the
severe toxicity of aminopterin in apn1 mutants may result
from unrepaired abasic sites blocking re-initiation of replica-
tion. Cells lacking uracil glycosylase (ung1) were able to
re-initiate DNA synthesis when placed in drug-free medium
following aminopterin treatment.Doublemutants lacking both
uracil glycosylase and Apn1 were able to re-enter the cell
cycle with kinetics similar to ung1 mutants. As shown in
Figure 2, the double mutant also showed signiﬁcantly less
aminopterin toxicity than apn1 mutants. The extreme sensitiv-
ity noted for apn1 mutants therefore appears to result from
blocked recovery following aminopterin exposure and not
from events or damage during the drug treatment itself.
DISCUSSION
The experiments described here examine the role of uracil
BER in mediating the toxicity of thymidine deprivation.
Mutants deﬁcient in various aspects of uracil BER were
determined to have altered sensitivity to thymidine depletion.
While most mutants in the uracil-BER pathway have subtle
effects on the toxicity of aminopterin mediated thymidine
depletion, apn1 mutants show a profound sensitivity. A mod-
est increase in sensitivity in apn1 mutants to the antifolate
trimetrexate has also been described by Simon et al. (33).
Aminopterin toxicity in wild-type cells and to a larger extent
in apn1 mutants appears to occur after drug exposure and is
potentially owing to blocked re-initiation of replication.
Figure 5. Cells from the experiment described in Figure 4 were collected, fixed in ethanol and stained with propidium iodide. DNA content was determined using
flow cytometry. While wild-typecells were able to resume DNA synthesisby 12 h after drug removal, apn1 mutants remained firmly fixed in S-phase.The vertical
line serves as a reference for the cell cycle position seen in the culture following 12 h of aminopterin treatment.
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has been suggested to overwhelm dUTPase (34,35). A role for
dUTP in thymidineless death is supported by the ﬁndings that
S.cerevisiae with decreased dUTPase activity are more sens-
itive to antifolate treatment (4) and human cancer cell lines
expressing elevated amounts of dUTPase are resistant to thy-
midine deprivation (36,37). Gadsden et al. (10) found the
toxicity of thymidine depletion in dut1 mutants of S.cerevisiae
was exacerbated inthedut1ung1doublemutant, abackground
favoring stable accumulation of uracil in DNA. In addition,
while the dut1 mutants died in S phase during thymidine
depletion (by cell morphology), the dut1 ung1 mutants died
throughout the cell cycle (unbudded, large and small budded
cells), leading the authors to conclude that excessive dUTP
accumulation led to a generalized failure in macromolecular
synthesis. It should be noted that only dut1 ung1 double
mutants showed this phenotype, implying that global tran-
scriptional failure may result only under conditions of low
TTP and very high dUTP afforded by the absence of dUTPase.
The extreme sensitivity of apn1 mutants demonstrated here
suggests a mechanism involving repair and/or cell cycle arrest
rather than alterations in global transcription rates.
Rampant DNA degradation resulting from attempted repair
of uracil laden DNA has also been suggested as a mechanism
of thymidineless death. However, manipulations of uracil
glycosylase alone have not resulted in major effects on the
toxicity of thymidine deprivation either in S.cerevisiae or
human cancer cells (4,8,36,37). Excess DNA damage does
not appear to be responsible for the signiﬁcant sensitivity of
apn1 mutants. Measures of DNA integrity, including the PCR
assay and ﬂow cytometry, failed to show increased DNA dam-
age in apn1 mutants. In addition, deletion of genes for repair
enzymes with AP lyase activity, NTG1 and NTG2, did not
relieve the sensitivity of apn1 deletion. Although inactivating
these genes may prevent formation of even more toxic repair
intermediates and has been shown to provide protection of
apn1 apn2 double mutants during methylation damage (25),
no survival advantage was seen in apn1 ntg1 ntg2 triple
mutants. Altogether, the data do not support excess DNA
damage as an explanation for the extreme sensitivity of
apn1 mutants.
A third possible mechanism for thymidineless death sug-
gests enzymes involved in uracil-BER interfere with the del-
icate process of S-phase arrest, replication fork stabilization
and replicationre-initiationwhenthymidineis again available.
Nucleotide pool imbalance leads to replication fork stalling
and cell cycle arrest by inducing S-phase checkpoints. This
process has been studied extensively in yeast using hydroxy-
urea, which depletes all dNTPs by inhibiting ribonucleotide
reductase. Mutants defective in S-phase arrest and replication
fork stabilization are very sensitive to hydroxyurea (32), high-
lighting the importance of these functions. Thymidine deple-
tion also causes cell cycle arrest in S phase (4) and Rad53
activation (31). Mutants deﬁcient in appropriate S-phase
arrest, e.g. mec1 and mec2 mutants, are sensitive to both
hydroxyurea and methotrexate (33). apn1 mutant cells, in
contrast to wild-type cells, remained ﬁxed in S-phase with
virtually no cell cycle progression 12 h after aminopterin
removal. apn1 mutants remained as viable as wild-type
cells after 12 h in aminopterin as assessed by methylene
blue viability staining. The lack of S-phase recovery seen
in apn1 mutants may be responsible for the toxicity in
these cells.
Unlike hydroxyurea, aminopterin treatment under the con-
ditions used in the experiments described here depletes only
thymidine and as mentioned above, dUTP may allow cells to
transiently overcome the thymidine deﬁciency (4). The use of
dUTP as a thymidine analog may allow more replication to
occur than during hydroxyurea treatment, but at the expense of
increased dUTP incorporation. The unique toxicity of thymi-
dine deprivation may result from interference with S-phase
checkpoints and stability of stalled replication forks by uracil-
BER proteins. Uracil glycosylase itself may interfere with
appropriate arrest or recovery by binding to either uracil-
DNA or abasic sites. Uracil glycosylase has been demon-
strated to localize to replication forks (38). In addition, Parikh
et al. (39) have shown that uracil glycosylase has a higher
afﬁnity for abasic sites than for uracil-DNA. It has been sug-
gested that BER enzymes interact with each other to shield
DNA repair intermediates from entering into more toxic
manipulations (40). AP endonuclease may serve to accelerate
the exit of uracil glycosylase from its product AP site and
thereby expedite the repair pathway. In vitro data have
shown that AP endonuclease facilitates the dissociation of
uracil glycosylase from its substrate and that the presence
of AP endonuclease stimulates the base excision activity of
uracil glycosylase (39). If Apn1 is absent, uracil glycosylase
may remain resident at the uracil-DNA site, inhibiting further
processing of the lesion either by repair or replication restart.
Human thymine-DNA glycosylase has also been shown to
bind tightly to abasic DNA produced by glycosylase action
(41). Our observation that an ung1 deletion rescues the
extreme sensitivity of apn1 mutants is consistent with this
possibility. The toxicity of dUTP incorporation may result
more from uracil-BER intermediates blocking recovery
from S-phase arrest than from strand cleavage and DNA
degradation.
Disruption of BER in mammalian cells also inﬂuences the
toxicity of thymidine depletion. Li et al. (42) used wild-type
and DNA polymerase b knockout murine embryo ﬁbroblasts
to show mutants deﬁcient in DNA repairsynthesis are resistant
to thymidine depletion. As shown in yeast in this study, arrest
kinetics during drug exposure were similar for both repair
proﬁcient and deﬁcient MEF cells. The repair synthesis
mutants were able to re-initiate replication more quickly
than wild-type cells. These ﬁndings again illustrate that repair
activities occurring after removal of thymidine synthesis
blockade determine the toxicity of thymidine deprivation.
The effect on survival from alterations in BER appear to be
dependent on which BER step is altered.
The profound toxicity engendered by loss of Apn1 seen in
these experiments suggests the possibility that manipulation of
Apn1 in mammalian cells may improve the effectiveness of
chemotherapy agents that act via thymidine depletion. Berry
et al. (43) used methoxylamine as an inhibitor of BER to alter
sensitivity of human and mouse cells to iododeoxyuridine.
Using a growth inhibition assay, the group was able to
show that methoxylamine further accentuates the growth
inhibitory effects of IUdR. Data fromthe present studysuggest
arrest and re-initiation of replication contribute signiﬁcantly to
the toxicity of thymidine deprivation, and therefore prolifera-
tion assays may provide a more accurate assessment of
Nucleic Acids Research, 2005, Vol. 33, No. 20 6651efﬁcacy compared with growth inhibition assays. Meth-
oxylamine inhibits completion of BER by binding to the
DNA substrate (44) and blocking strand incision. An altern-
ative strategy would be to inhibit Apn1 directly, allowing
uracil glycosylase to bind to uracil laden DNA and inhibit
re-entry into the cell cycle. The possibility that AP endonuc-
lease inhibition at the enzyme level potentiates the cytotox-
icity of thymidine depletion in human cancer cells is currently
under investigation.
The data presented in this paper suggest that the toxicity of
thymidine deprivation occurs in large part after the thymidine
depleting agent has been removed and that re-initiation of
replication is a particularly sensitive event during thymidine
depletion. Interruption of uracil-BER at the abasic endonuc-
lease step produced extreme cytotoxicity. These ﬁndings pro-
vide a rationale for understanding thymidineless death in the
context of interference between uracil-BER and replication
arrest and re-initiation. The presence of uracil and uracil glyc-
osylase in the vicinity of stalled replication forks adds to the
complexity of replication fork stalling and re-initiation, which
has been well described for dNTP depletion via hydroxyurea.
The ﬁndings also provide a rationale for manipulating abasic
endonuclease and S-phase arrest functions during recovery
from thymidine depletion as a means to potentiate the
cytotoxicity of chemotherapy agents working via thymidine
depletion.
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